Are Sakar Healthcare Ltd latest results good or bad?

Sakar Healthcare Ltd's latest financial results for the quarter ended March 2026 demonstrate notable operational performance, characterized by substantial year-on-year growth across key metrics. The company reported a net profit of ₹11.02 crores, reflecting a significant increase of 91.32% compared to the same quarter last year. This growth in net profit was accompanied by a revenue of ₹71.10 crores, which also showed a robust year-on-year increase of 41.52%. The operating margin, excluding other income, reached 36.91%, marking the highest level in the company's recent history and indicating effective cost management and operational efficiency. This margin expansion of 560 basis points from the previous year underscores the company's ability to scale revenues while controlling expenses. Additionally, the profit before tax surged to ₹18.06 crores, up 64.90% quarter-on-quarter and 189.42% year-on-year, driven by both revenue growth and improved margins. However, the quarter also saw a notable rise in the effective tax rate, which increased to 38.98%, impacting the net profit flow-through from pre-tax gains. Despite this, the net profit margin improved to 15.50%, up from 11.46% year-on-year, reflecting the underlying strength of the company's operational performance. The company has also experienced a revision in its evaluation, reflecting its strong operational metrics and performance. While the financial results indicate a positive trajectory in terms of growth and profitability, there are concerns regarding working capital management, as evidenced by a decline in the debtor turnover ratio, which may affect cash flows if not addressed. Overall, Sakar Healthcare Ltd's financial results highlight a strong operational execution with significant revenue and profit growth, although attention is warranted on working capital efficiency and the implications of increased tax rates on future profitability.